Navigation Links
Industry and academic researchers gather for innovative accelerating cancer cures research symposium

Cambridge, MA (March 4, 2013) Today, the Damon Runyon Cancer Research Foundation held its annual Accelerating Cancer Cures Research Symposium designed to foster communication and collaboration between cancer researchers in industry and academia to speed progress against cancer. Hosted by Millennium: The Takeda Oncology Company, the meeting included physician-scientists from Eli Lilly and Company, ARIAD, Celgene, Genentech, Merck, and Pfizer, as well as academic researchers from the top universities and research institutions in the nation.

Accelerating Cancer Cures is a unique collaboration between Damon Runyon, a prestigious cancer charity that supports the most innovative young cancer researchers, and leading biopharmaceutical companies. The goal of this multi-million dollar initiative is to rebuild the ranks of specially trained physician-scientists who conduct both the cutting-edge laboratory research to identify new therapeutics, as well as the clinical trials to bring these new treatments to patients. The companies involved in this initiative, while competitors in the marketplace, are committed to supporting the best young clinical investigators so that they can drive the next breakthroughs in cancer prevention, diagnosis and treatment.

The President and CEO of Millennium, Dr. Deborah Dunsire, opened the meeting with remarks that focused on the need for greater collaboration between industry and academia. Additionally, David Nathan, MD, President Emeritus, Dana-Farber Cancer Institute, and the Robert A. Stranahan Distinguished Professor of Pediatrics and Professor of Medicine, Harvard Medical School, delivered a keynote address about the promise of cancer research and the critical role of patient-oriented physician-scientists in advancing progress against the many forms of cancer. Richard B. Gaynor, MD, Vice President, Cancer Research/Clinical Investigation, of Lilly, and Alan Leventhal, Chairman and CEO of Beacon Capital Partners and Chairman of the Board of the Damon Runyon Cancer Research Foundation, also spoke about this groundbreaking collaboration.

"It is extraordinary that industry competitors have come together to address a major obstacle to developing new treatments for cancer patients," said Damon Runyon Cancer Research Foundation President and CEO, Lorraine Egan. "Through Accelerating Cancer Cures, we are ensuring that the best young physician-scientists can continue to be the critical link between the research lab and the patients."

"The future of oncology research and the creation of novel treatments rests in the hands of talented scientific leaders like those who are presenting at this year's Accelerating Cancer Cures symposium, which Millennium is proud to host," stated Dr. Karen Ferrante, Chief Medical Officer, Millennium: The Takeda Oncology Company. "This event underscores the importance of collaboration between the biopharmaceutical industry and its academic partners, and how these partnerships will ultimately create new cancer treatments for patients."

Scientists from the nation's leading research institutions, including the Dana-Farber Cancer Institute, Memorial Sloan-Kettering Cancer Center, Fred Hutchinson Cancer Research Center, Stanford University, the University of Texas MD Anderson Cancer Center, and the University of North Carolina, Chapel Hill, attended the symposium to hear presentations on a diverse range of promising research, from advances in colorectal cancer detection to novel therapeutic approaches to breast cancers, and to brainstorm about new approaches to speed new treatments to cancer patients.

Contact: Yung S. Lie
Damon Runyon Cancer Research Foundation

Related medicine news :

1. MSU invention could help pharmaceutical industry save money
2. More cutting-edge cancer research supported by industry
3. Ultra-short laser pulses for science and industry
4. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
5. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
6. Advertising Industry Veteran Pat McCrossan Joins Mangos
7. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
8. QTrade's New Facility Anticipates Dramatic Growth of Tea Industry
9. A Void In The Independent Pharmacy Industry Leads to Independent Rx Consulting, Powered by OurHelix
10. Massage Industry Heavyweights Team Up for First-Ever Massage Documentary
11. Butter flavoring in microwave popcorn, thought safe for food industry workers, is respiratory hazard
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
Breaking Medicine Technology: